Exela Wins PCH Global Rollout for a National Leader in Post-Acute Healthcare
Exela Technologies (NASDAQ: XELA) announced a partnership with a national leader in post-acute healthcare focused on home healthcare and personal care as of January 21, 2022. This collaboration will enhance PCH Global's capabilities in data aggregation and reporting, facilitating access to high-quality care for patients. The PCH Global platform aims for improved claim resolution, payment transparency, and digital appeals, supported by a scalable cloud network with high uptime. The partnership highlights Exela's expertise in addressing complex healthcare needs.
- New partnership with a leader in post-acute healthcare enhancing PCH Global's data capabilities.
- Improved cloud-hosted solution for healthcare claims with high uptime and business continuity.
- PCH Global offers enhanced data analytics, facilitating self-service access.
- None.
IRVING, Texas, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela”) (NASDAQ: XELA) today announced a new relationship with a national leader in post-acute healthcare focusing on home healthcare, hospice and personal care. The initial scope of the PCH Global rollout will deliver data aggregation and reporting to drive easier access to personalized high-quality care for patients and their families.
Exela continues to invest in expanding PCH Global’s capabilities to provide a cloud hosted solution with one of the best edit resolutions for healthcare claims. This marks another milestone in the value proposition of the PCH Global platform to digitally connect members, providers and insurance companies to enable clean claims, payment transparency and digital appeals. PCH Global’s cloud network offers increased scalability, the highest uptime and best business continuity protections. PCH Global has robust data analytics which are continually improving as Exela processes more and more data. Additionally, PCH Global’s improved data analytics can be accessed via a self-service model.
“This new relationship highlights the breadth of expertise within our healthcare solutions that can cater to every facet of the complex global healthcare landscape,” said Suresh Yannamani, President of Exela. Adding “we look forward to expanding our PCH Global services to drive high quality outcomes for all of our customers.”
For more Exela news, commentary, and industry perspectives, visit: https://investors.exelatech.com/
And please follow us on social:
Twitter: https://twitter.com/exelatech
LinkedIn: https://www.linkedin.com/company/exela-technologies
Facebook: https://www.facebook.com/exelatechnologies/
Instagram: https://www.instagram.com/exelatechnologies
The information posted on the Company's website and/or via its social media accounts may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website and its social media accounts in addition to the Company's press releases, SEC filings and public conference calls and webcasts.
About Exela Technologies
Exela Technologies is a business process automation (BPA) leader, leveraging a global footprint and proprietary technology to provide digital transformation solutions enhancing quality, productivity, and end-user experience. With decades of experience operating mission-critical processes, Exela serves a growing roster of more than 4,000 customers throughout 50 countries, including over
Forward-Looking Statements
Certain statements included in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "may", "should", "would", "plan", "intend", "anticipate", "believe", "estimate", "predict", "potential", "seem", "seek", "continue", "future", "will", "expect", "outlook" or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, estimated or anticipated future results and benefits, future opportunities for Exela, and other statements that are not historical facts. These statements are based on the current expectations of Exela management and are not predictions of actual performance. These statements are subject to a number of risks and uncertainties, including without limitation those discussed under the heading "Risk Factors" in Exela's Annual Report and other securities filings. In addition, forward-looking statements provide Exela's expectations, plans or forecasts of future events and views as of the date of this communication. Exela anticipates that subsequent events and developments will cause Exela's assessments to change. These forward-looking statements should not be relied upon as representing Exela's assessments as of any date subsequent to the date of this press release.
Investor and/or Media Contacts:
Vincent Kondaveeti
E: vincent.kondaveeti@exelatech.com
Mary Beth Benjamin
E: IR@exelatech.com
FAQ
What is the new partnership announced by Exela Technologies on January 21, 2022?
How does the partnership affect Exela Technologies' PCH Global platform?
What are the benefits of the PCH Global platform mentioned in the January 2022 press release?